Table 1.
Characteristic | No infertility | History of infertility | ||
---|---|---|---|---|
No hormone treatment | Hormonal treatment onlya | COS for IVF/ICSIb | ||
(n = 34,360) | (n = 5948) | (n = 1429) | (n = 1576) | |
Absolute dense volume, cm3 | 62.8 ± 33.2 | 64.0 ± 33.7 | 64.8 ± 31.4 | 73.8 ± 41.5 |
Absolute non-dense volume, cm3 | 773 ± 466 | 805 ± 470 | 804 ± 499 | 706 ± 465 |
Percent dense volume, pp | 9.2 ± 5.2 | 9.0 ± 5.2 | 9.3 ± 5.2 | 11.4 ± 5.8 |
Age at mammography, years, % | ||||
40–44 | 20.9 | 16.4 | 22.9 | 42.5 |
45–49 | 19.1 | 17.2 | 20.4 | 28.7 |
50–54 | 18.3 | 17.2 | 19.9 | 18.3 |
55–59 | 13.4 | 15.1 | 15.3 | 8.3 |
60–64 | 14.0 | 16.6 | 12.5 | 1.8 |
65–69 | 14.4 | 17.5 | 9.0 | 0.3 |
BMI, kg/m2, % | ||||
<18.5 | 0.8 | 1.0 | 1.0 | 1.4 |
18.5–24.9 | 55.7 | 53.6 | 54.9 | 61.7 |
25–29.9 | 30.9 | 32.6 | 29.5 | 27.0 |
≥30 | 12.6 | 12.8 | 14.6 | 9.8 |
Age at menarche, years, % | ||||
<12 | 12.6 | 14.2 | 14.1 | 16.1 |
12–14 | 72.0 | 70.5 | 69.7 | 70.7 |
≥15–25 | 15.3 | 15.3 | 16.2 | 13.2 |
Cigarette smoking, % | ||||
Never | 48.7 | 46.0 | 50.7 | 57.4 |
Current | 11.3 | 10.8 | 9.2 | 7.2 |
Former | 40.0 | 43.2 | 40.2 | 35.3 |
Alcohol consumption, g/d, % | ||||
Non-drinker | 18.3 | 17.3 | 17.4 | 15.5 |
0.1–9.9 | 62.1 | 61.2 | 62.8 | 67.8 |
≥10 | 19.5 | 21.5 | 19.9 | 16.7 |
Education level, % | ||||
Compulsory school | 10.9 | 12.0 | 6.9 | 2.5 |
Upper secondary school | 31.6 | 31.1 | 32.4 | 25.5 |
University | 54.3 | 53.1 | 56.8 | 69.2 |
Other | 3.2 | 3.9 | 3.9 | 2.8 |
Family history of breast cancer, % | 12.5 | 12.7 | 13.6 | 12.1 |
Parity, % | ||||
Nulliparous | 10.8 | 17.3 | 14.4 | 31.3 |
One birth | 12.3 | 19.3 | 21.6 | 27.5 |
Two births | 50.4 | 44.2 | 43.5 | 31.5 |
Three or more births | 26.6 | 19.2 | 20.4 | 9.7 |
Premenopausal, % | 46.1 | 39.3 | 50.2 | 73.9 |
Plus-minus values are means ± standard deviation
Abbreviations: BMI body mass index, COS controlled ovarian stimulation, HRT hormone replacement therapy, ICSI intracytoplasmic sperm injection, IVF in vitro fertilization, pp percentage points
aHormonal treatment includes ovulation induction with clomiphene citrate or low-dose gonadotropins
bCOS for IVF/ICSI treatment includes high-dose gonadotropin stimulation for multiple follicle recruitment and superovulation